Protective effects of Mg-CUD against D-galactosamine-induced hepatotoxicity in rats

European Journal of Pharmacology

Volumn 657, Issue 1-3, 2011, Pages 138-143

  Choi, Jun Ho ^a   Kang, Jung Woo ^a   Kim, Dong Wook ^a   Sung, Yong Kyung ^b   Lee, Sun Mee ^a  

^a Sungkyunkwan University   (South Korea)

^b Myungmoon B/D   (South Korea)

Author keywords

CDCA; D galactosamine; Hepatitis; Hepatotoxicity; Mg CUD; UDCA

Indexed keywords

ALANINE AMINOTRANSFERASE; CHENODEOXYCHOLIC ACID DERIVATIVE; GALACTOSAMINE; GLUTATHIONE; HEME OXYGENASE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAGNESIUM CHENOURSODEOXYCHOLIC ACID; MESSENGER RNA; PROTEIN C JUN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID DERIVATIVE;

ACUTE HEPATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ANIMALS; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE DISULFIDE; HEME OXYGENASE-1; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPID PEROXIDATION; LIVER; MALE; NF-KAPPA B; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSAMINASES; TUMOR NECROSIS FACTOR-ALPHA; URSODEOXYCHOLIC ACID;

EID: 79952487211     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.01.030     Document Type: Article

References (37)

1. K. Abe, M. Ijiri, T. Suzuki, K. Taguchi, Y. Koyama, and M. Isemura Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liver Biomed. Res. 26 2005 187 192
2. J.J. Albers, S.M. Grundy, P.A. Cleary, D.M. Small, J.M. Lachin, and L.J. Schoenfield National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins Gastroenterology 82 1982 638 646 (Pubitemid 12179964)
3. S. Arisawa, K. Ishida, N. Kameyama, J. Ueyama, A. Hattori, Y. Tatsumi, H. Hayashi, M. Yano, K. Hayashi, Y. Katano, H. Goto, K. Takagi, and S. Wakusawa Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells Biochem. Pharmacol. 77 2009 858 866
4. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Meth. Enzymol. 52 1978 302 310
5. S. Camandola, A. Scavazza, G. Leonarduzzi, F. Biasi, E. Chiarpotto, A. Azzi, and G. Poli Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-kappa B in cells of the macrophage lineage Biofactors 6 1997 173 179 (Pubitemid 27487822)
6. R.G. Danzinger, A.F. Hofmann, L.J. Schoenfield, and J.L. Thistle Dissolution of cholesterol gallstones by chenodeoxycholic acid N. Engl. J. Med. 286 1972 1 8
7. J.A. Diaz-Buxo, S. Blumenthal, D. Hayes, P. Gores, and B. Gordon Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines Hepatology 25 1997 950 957 (Pubitemid 27157140)
8. C. Galanos, M.A. Freudenberg, and W. Reutter Galactosamine-induced sensitization to the lethal effects of endotoxin Proc. Natl Acad. Sci. USA 76 1979 5939 5943 (Pubitemid 10216692)
9. D. Gleeson, D.C. Ruppin, A. Saunders, G.M. Murphy, and R.H. Dowling Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones Q. J. Med. 76 1990 711 729 (Pubitemid 20214403)
10. O.W. Griffith Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine Anal. Biochem. 106 1980 207 212 (Pubitemid 11246585)
11. H.L. Hu, and R.D. Chen Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine Biol. Trace Elem. Res. 34 1992 19 25
12. T. Ishii, K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai, and M. Yamamoto Transcriptional factor Nrf2 coordinately regulates a group of oxidative stress-inducivle genes in macrophages J. Biol. Chem. 275 2000 16023 16029 (Pubitemid 30366908)
13. H. Louis, L.O. Moine, M.O. Peny, E. Quertinmont, D. Fokan, M. Goldman, and J. Deviere Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice Hepatology 25 1997 1382 1389 (Pubitemid 27250758)
14. D.D. Mariana, and A.S. David Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration Am. J. Pathol. 143 1993 1606 1620
15. P.N. Maton, G.M. Murphy, and R.H. Dowling Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action Lancet 2 1977 1297 1301 (Pubitemid 8252723)
16. S.K. Mitra, S.J. Seshadri, M.V. Venkataranganna, S. Gopumadhavan, U.V. Udupa, and D.N. Sarma Effect of HD-03-a herbal formulation in galactosamine-induced hepatopathy in rats Indian J. Physiol. Pharmacol. 44 2000 82 86 (Pubitemid 30090038)
17. H.Y. Mok, G.D. Bell, and R.H. Dowling Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones Lancet 2 1974 253 257
18. D. Moradpour, and H.E. Blum Pathogenesis of hepatocellular carcinoma Eur. J. Gastroenterol. Hepatol. 17 2005 477 483 (Pubitemid 40592703)
19. J.J. O'Shea, and P.J. Murray Cytokine signaling modules in inflammatory responses Immunity 28 2008 477 487 (Pubitemid 351467044)
20. G. Paumgartner, and U. Beuers Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease Clin. Liver Dis. 8 2004 67 81 (Pubitemid 38373670)
21. M. Podda, M. Zuin, M.L. Dioguardi, S. Festorazzi, and N. Dioguardi A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation Hepatology 2 1982 334 339 (Pubitemid 12011902)
22. M. Podda, M. Zuin, P.M. Battezzati, C. Ghezzi, C. Fazio, and M.L. Dioguardi Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone Gastroenterology 96 1989 222 229 (Pubitemid 19046286)
23. M. Podda, C. Ghezzi, P.M. Battezzati, A. Crosignani, M. Zuin, and A. Roda Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis Gastroenterology 98 1990 1044 1050 (Pubitemid 20095860)
24. R. Roehrkasse, H. Fromm, M. Malavolti, A.K. Tunuguntla, and S. Ceryak Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids Dig. Dis. Sci. 31 1986 1032 1040 (Pubitemid 16025638)
25. J. Rudi, T. Schlenker, R. Raedsch, R. Waldherr, M. Zorn, and W. Stremmel Effect of ursodeoxycholic acid on biochemical parameters, hepatocyte proliferation and liver histology in galactosamine hepatitis in the rat Res. Exp. Med. (Berl) 195 1995 309 315
26. S. Sakaguchi, and K. Yokota Role of Ca2+ on endotoxin-sensitivity by galactosamine challenge: lipid peroxide formation and hepatotoxicity in zymosan-primed mice Pharmacol. Toxicol. 77 1995 81 86
27. G. Serviddio, J. Pereda, F.V. Pallardo, J. Garretero, C. Borras, J. Cutrin, G. Vendemiale, G. Pol, J. Vina, and J. Sastre Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress Hepatology 39 2004 711 720 (Pubitemid 38337650)
28. S.D. Skaper, M. Fabris, V. Ferrari, C.M. Dalle, and A. Leon Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid Free Radic. Biol. Med. 22 1997 669 678 (Pubitemid 27043403)
29. R.F. Stachlewitz, V. Seabra, B. Bradford, C.A. Bradham, I. Rusyn, D. Germolec, and R.G. Thurman Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells Hepatology 29 1999 737 745 (Pubitemid 29109587)
30. A. Stiehl, R. Raedsch, P. Czygan, R. Gotz, C. Manner, S. Walker, and B. Kommerell Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid Gastroenterology 79 1980 1192 1198 (Pubitemid 11250459)
31. M. Takanori, O. Rika, Y. Noritada, O. Kensaku, M. Yuichi, N. Tetsuya, M. Chikao, M. Isao, and T. Hirotoshi Functional modulation of the glucocorticoid receptor and suppression of NF-κB-dependent transcription by ursodeoxycholic acid J. Biol. Chem. 276 2001 47371 47378
32. J.L. Thistle, and L.J. Schoenfield Induced alterations in composition of bile of persons having cholelithiasis Gastroenterology 61 1971 488 496
33. P. Thomas, V. Timo, W. Ralf, U.D. Gerald, B. Ulrich, and R. Christian Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1 Biochem. Biophys. Res. Commun. 367 2008 208 212
34. F. Tietze Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Anal. Biochem. 27 1969 502 522
35. J.Y. Wan, X. Gong, L. Zhang, H.Z. Li, Y.F. Zhou, and Q.X. Zhou Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1 Eur. J. Pharmacol. 587 2008 1 3
36. D. Yan, Y. Yang, S. Uchida, S. Misaka, J. Luo, K. Takeuchi, N. Inui, S. Yamada, K. Ohashi, and H. Watanabe Effects of ursodeoxycholic acid on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam in healthy volunteers Naunyn. Schmiedeberg's Arch. Pharmacol. 377 2008 4 6
37. K. Yasukawa, T. Iida, and Y. Fujimoto Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumor promotion in mouse skin two-stage carcinogenesis J. Pharm. Pharmacol. 61 2009 1051 1056